114 related articles for article (PubMed ID: 36736872)
21. Pharmacodynamics of pentoxifylline and/or praziquantel in murine schistosomiasis mansoni.
El-Lakkany N; Nosseir M
APMIS; 2007 Mar; 115(3):184-94. PubMed ID: 17367463
[TBL] [Abstract][Full Text] [Related]
22. Improvement of the oral praziquantel anthelmintic effect by cyclodextrin complexation.
de Jesus MB; Pinto Lde M; Fraceto LF; Magalhães LA; Zanotti-Magalhães EM; de Paula E
J Drug Target; 2010 Jan; 18(1):21-6. PubMed ID: 19624246
[TBL] [Abstract][Full Text] [Related]
23. In vivo activity of dihydroartemisinin against Schistosoma mansoni schistosomula in mice.
Li HJ; Wang W; Li YZ; Qu GL; Xing YT; Qian K; Jia Y; Yang ZK; Qian YL; Dai JR; Liang YS
Southeast Asian J Trop Med Public Health; 2013 May; 44(3):379-87. PubMed ID: 24050069
[TBL] [Abstract][Full Text] [Related]
24. Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo.
Liang YS; Coles GC; Dai JR; Zhu YC; Doenhoff MJ
J Helminthol; 2002 Dec; 76(4):327-33. PubMed ID: 12498638
[TBL] [Abstract][Full Text] [Related]
25. Discovery and Characterization of Novel Anti-schistosomal Properties of the Anti-anginal Drug, Perhexiline and Its Impact on Schistosoma mansoni Male and Female Reproductive Systems.
Guidi A; Lalli C; Perlas E; Bolasco G; Nibbio M; Monteagudo E; Bresciani A; Ruberti G
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004928. PubMed ID: 27518281
[TBL] [Abstract][Full Text] [Related]
26. Effects of iron chelating agent on Schistosoma mansoni infected murine model.
Abdelgelil NH; Abdellatif MZM; Abdel-Hafeez EH; Belal US; Mohamed RM; Abdel-Razik AH; Hassanin KMA; Abdel-Wahab A
Biomed Pharmacother; 2019 Jan; 109():28-38. PubMed ID: 30391706
[TBL] [Abstract][Full Text] [Related]
27. Bioavailability and in vivo efficacy of a praziquantel-polyvinylpyrrolidone solid dispersion in Schistosoma mansoni-infected mice.
El-Lakkany N; Seif El-Din SH; Heikal L
Eur J Drug Metab Pharmacokinet; 2012 Dec; 37(4):289-99. PubMed ID: 22460595
[TBL] [Abstract][Full Text] [Related]
28.
Tavares NC; Gava SG; Torres GP; de Paiva CÊS; Moreira BP; Lunkes FMN; Montresor LC; Caldeira RL; Mourão MM
Front Microbiol; 2020; 11():963. PubMed ID: 32595609
[TBL] [Abstract][Full Text] [Related]
29. Parasitological and histo-pathological studies on schistosomiasis mansoni infected mice and treated with praziquatel and/or oltipraz.
Morsy GH
J Egypt Soc Parasitol; 2009 Aug; 39(2):687-701. PubMed ID: 19795775
[TBL] [Abstract][Full Text] [Related]
30. Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel.
Amer EI; Abou-El-Naga IF; Boulos LM; Ramadan HS; Younis SS
Biomedica; 2022 Mar; 42(1):67-84. PubMed ID: 35471171
[TBL] [Abstract][Full Text] [Related]
31. Antischistosomal effects of
El-Morsy SMA; El-Tantawy SAM; El-Shabasy EA
J Parasit Dis; 2022 Mar; 46(1):87-102. PubMed ID: 35299912
[TBL] [Abstract][Full Text] [Related]
32. Characterization of beta-lapachone and methylated beta-cyclodextrin solid-state systems.
Cunha-Filho MS; Dacunha-Marinho B; Torres-Labandeira JJ; Martínez-Pacheco R; Landín M
AAPS PharmSciTech; 2007 Jul; 8(3):E60. PubMed ID: 17915810
[TBL] [Abstract][Full Text] [Related]
33. In vivo effect of single oral dose of artemether against early juvenile stages of Schistosoma mansoni Egyptian strain.
El-Beshbishi SN; Taman A; El-Malky M; Azab MS; El-Hawary AK; El-Tantawy DA
Exp Parasitol; 2013 Oct; 135(2):240-5. PubMed ID: 23876575
[TBL] [Abstract][Full Text] [Related]
34. Schistosomal granuloma modulation. III. Schistosma haematobium worms accelerate S. mansoni soluble egg antigen-induced hepatic granuloma formation in vivo.
Jacobs W; Deelder A; Bogers J; Van de Vijver K; Van Marck E
Parasitol Res; 1999 Nov; 85(11):905-9. PubMed ID: 10540951
[TBL] [Abstract][Full Text] [Related]
35. DNA vaccination using recombinant Schistosoma mansoni fatty acid binding protein (smFABP) gene.
Aly I; ELnain G; Hamad RS; Kilany M; Ghramh HA; Alshehri A; Dajem SM; Ibrahim EH
Exp Parasitol; 2018 Nov; 194():53-59. PubMed ID: 30266572
[TBL] [Abstract][Full Text] [Related]
36. In vivo schistosomicidal activity of three novels 8-hydroxyquinoline derivatives against adult and immature worms of Schistosoma mansoni.
Allam G; Eweas AF; Abuelsaad AS
Parasitol Res; 2013 Sep; 112(9):3137-49. PubMed ID: 23793335
[TBL] [Abstract][Full Text] [Related]
37. Assessment of various formulation approaches for the application of beta-lapachone in prostate cancer therapy.
Wu X; Kasselouri A; Vergnaud-Gauduchon J; Rosilio V
Int J Pharm; 2020 Apr; 579():119168. PubMed ID: 32087264
[TBL] [Abstract][Full Text] [Related]
38. Effect of the in vivo activity of dihydroartemisinin against Schistosoma mansoni infection in mice.
Li HJ; Wang W; Qu GL; Li YZ; Tao YH; Xing YT; Wang XT; Dai Y; Wei JY; Dai JR; Coles GC; Liang YS
Parasitol Res; 2012 May; 110(5):1727-32. PubMed ID: 22006193
[TBL] [Abstract][Full Text] [Related]
39. Diloxanide furoate binary complexes with β-, methyl-β-, and hydroxypropyl-β-cyclodextrins: inclusion mode, characterization in solution and in solid state and in vitro dissolution studies.
Aloisio C; Longhi M
Pharm Dev Technol; 2018 Sep; 23(7):723-731. PubMed ID: 28758845
[TBL] [Abstract][Full Text] [Related]
40. Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis.
El-Lakkany NM; Hammam OA; El-Maadawy WH; Badawy AA; Ain-Shoka AA; Ebeid FA
Parasit Vectors; 2012 Jan; 5():9. PubMed ID: 22236605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
